After Dr. Ron Liu founded AustarPharma in NJ, USA in 2004, he founded Bostal Drug Delivery in Guangzhou, China in 2013. Both AustarPharma and Bostal are drug delivery technology based enterprises with focusing on the markets of US and China, respectively. After the acquisition of Abbott’s R&D and GMP manufacturing facility in 2009, AustarPharma currently has about 70 employees, with its location at Edison, NJ USA. Bostal is located in Guangzhou and has about 500 employees. Both facilities have passed multiple FDA, EU and other authorities’ GMP inspections and are equipped with state-of-the-art laboratories and GMP commercial manufacturing facilities. The Company has developed world class platform technologies with commercial manufacturing capabilities. The pipelines of the Company cover the therapeutic areas include metabolic, CNS, oncology, immunology, and cardiovascular.